Effects of zinc on the interleukin-1 and tumor necrosis factor in experimental silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 517s Year: 2002
Tuberculosis and tumor necrosis factor alpha antagonist: Our experience Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats Source: Eur Respir J 2004; 23: 752-758 Year: 2004
Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002
Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005
Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Mycobacterial diseases developed during anti-tumour necrosis factor alpha therapy Source: Eur Respir J 2014; 44: 1289-1295 Year: 2014
Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007
Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007
Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis Source: Eur Respir J 2002; 20: 1179-1184 Year: 2002
Analysis of tumor necrosis factor receptor 1 (TNFR1) polymorphisms in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001
Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001
Predictors of elevated tumour necrosis factor α level in obstructive sleep apnoea syndrome Source: Eur Respir Rev 2006; 15: 221-223 Year: 2006
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Tumor necrosis factor-α and interleukin-6 gene polymorphisms in pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial Source: Eur Respir J 2014; 43: 295-298 Year: 2004
The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006
Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002